CD4 and Kaposi's sarcoma: Univariate analysis identified MSM, CD4 count <100 cells/μL, HIV RNA VL ≥10,000 copies/mL, no history of HAART, and the presence of cutaneous KS as significant clinical factors for the development of GI-KS (Table 2).